<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02095080</url>
  </required_header>
  <id_info>
    <org_study_id>H14-00235</org_study_id>
    <nct_id>NCT02095080</nct_id>
  </id_info>
  <brief_title>Determination of the UL of Leucine in Healthy Elderly Men</brief_title>
  <official_title>Determination of the Tolerable Upper Intake Level (UL) of Leucine in Healthy Elderly Men (70-75 Yrs)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Council on Amino Acid Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amino acid are the building blocks of the body's protein. Some amino acids, including&#xD;
      leucine, cannot be made in the body and must be obtained from diet, these are called&#xD;
      essential. With increase in age the body's muscle mass decrease and studies have suggested&#xD;
      that dietary supplementation of leucine may have potential health benefits in elderly in&#xD;
      regards to prevention of age related loss of lean muscle mass, and thus may help improve the&#xD;
      quality of life in elderly.&#xD;
&#xD;
      Currently, a safe upper dietary intake level of leucine has not been established for healthy&#xD;
      elderly. Prior to exploring whether leucine supplementation will prevent or decrease loss of&#xD;
      lean muscle mass in elderly we propose to identify the upper intake of leucine in healthy&#xD;
      elderly.&#xD;
&#xD;
      The purpose of this study is to determine the tolerable upper intake level (UL) of leucine in&#xD;
      healthy elderly men (70 - 75 yrs)&#xD;
&#xD;
      The investigators hypothesize that with a careful graded stepwise increase in leucine intake&#xD;
      in elderly men, above the Estimated Average Requirement (EAR - 50 mg/kg/d), the body's&#xD;
      ability to oxidize/dispose of excess amino acids will reach a maximum. With increased leucine&#xD;
      intakes we hypothesize an increase in plasma ammonia concentrations and increases in plasma&#xD;
      leucine and urinary leucine excretion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>13 carbon dioxide production</measure>
    <time_frame>8 hours (1 study day)</time_frame>
    <description>Urine, plasma and breath samples will be collected during the study to measure the rate of oxidation of the tracer.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Elderly Men</condition>
  <arm_group>
    <arm_group_label>Leucine intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary supplement: Leucine intake</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Leucine intake</intervention_name>
    <description>Oral consumption of eight hourly experimental meals- Includes 4 tracer-free experimental meals containing a mixture of free amino acids, calories from a flavored liquid and protein free cookies and 4- labeled amino acid experimental meals.</description>
    <arm_group_label>Leucine intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men 70 - 75 years of age&#xD;
&#xD;
          -  Free of chronic diseases including; sarcopenia, heart disease, kidney disorders, liver&#xD;
             disease, chronic high blood pressure and or diabetes.&#xD;
&#xD;
          -  Free of any cognitive disorders&#xD;
&#xD;
          -  Men not enrolled in any other research studies&#xD;
&#xD;
          -  Men who are not claustrophobic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Men not within the age 70 -75 years&#xD;
&#xD;
          -  Men diagnosed with a chronic diseases including; sarcopenia, heart disease, kidney&#xD;
             disorders, liver disease, chronic high blood pressure and/or diabetes&#xD;
&#xD;
          -  Men allergic to milk, eggs and egg protein&#xD;
&#xD;
          -  Men who are claustrophobic&#xD;
&#xD;
          -  Men who are currently enrolled in other research studies&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajavel Elango, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Child &amp; Family Research Institute/University of British Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Child &amp; Family Research Institute</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>March 19, 2014</study_first_submitted>
  <study_first_submitted_qc>March 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2014</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Rajavel Elango, PhD</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>Leucine</keyword>
  <keyword>Upper Intake Level (UL)</keyword>
  <keyword>Elderly</keyword>
  <keyword>Amino acids</keyword>
  <keyword>Protein</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

